Gene cloning, expression and immune adjuvant properties of the recombinant fusion peptide Tα1-BLP on avian influenza inactivate virus vaccine

2018 ◽  
Vol 120 ◽  
pp. 147-154 ◽  
Author(s):  
Cong Zhang ◽  
Jiangfei Zhou ◽  
Kairui Cai ◽  
Wufan Zhang ◽  
Chengshui Liao ◽  
...  
Keyword(s):  
Avian Influenza ◽  
Gene Cloning ◽  
Virus Vaccine ◽  
Fusion Peptide ◽  
Immune Adjuvant

scholarly journals Interaction between avian influenza subtype H9N2 and Newcastle disease virus vaccine strain (LaSota) in chickens

2018 ◽  
Vol 14 (1) ◽  
Author(s):  
Hany F. Ellakany ◽  
Ahmed R. Gado ◽  
Ahmed R. Elbestawy ◽  
Hatem S. Abd El-Hamid ◽  
Hafez M. Hafez ◽  
...  
Keyword(s):  
Avian Influenza ◽  
Newcastle Disease Virus ◽  
Disease Virus ◽  
Vaccine Strain ◽  
Virus Vaccine ◽  
Newcastle Disease ◽  
Newcastle Disease Virus Vaccine

scholarly journals A pilot study of the immune response to whole inactivated avian influenza H7N1 virus vaccine in mice

2009 ◽  
Vol 3 (1) ◽  
pp. 21-28 ◽  
Author(s):  
Arnt-Ove Hovden ◽  
Karl A. Brokstad ◽  
Diane Major ◽  
John Wood ◽  
Lars R. Haaheim ◽  
...  
Keyword(s):  
Immune Response ◽  
Pilot Study ◽  
Avian Influenza ◽  
Virus Vaccine ◽  
H7n1 Virus

scholarly journals The Application of NHEJ-CRISPR/Cas9 and Cre-Lox System in the Generation of Bivalent Duck Enteritis Virus Vaccine against Avian Influenza Virus

Viruses ◽  
2018 ◽  
Vol 10 (2) ◽  
pp. 81 ◽  
Author(s):  
Pengxiang Chang ◽  
Yongxiu Yao ◽  
Na Tang ◽  
Jean-Remy Sadeyen ◽  
Joshua Sealy ◽  
...  
Keyword(s):  
Influenza Virus ◽  
Avian Influenza ◽  
Avian Influenza Virus ◽  
Virus Vaccine ◽  
Duck Enteritis Virus ◽  
Enteritis Virus

scholarly journals Induction of immune response in chickens primed in ovo with an inactivated H9N2 avian influenza virus vaccine

2018 ◽  
Vol 11 (1) ◽  
Author(s):  
Jake Astill ◽  
Tamiru Alkie ◽  
Alexander Yitbarek ◽  
Khaled Taha-Abdelaziz ◽  
Jegarubee Bavananthasivam ◽  
...  
Keyword(s):  
Immune Response ◽  
Influenza Virus ◽  
Avian Influenza ◽  
Avian Influenza Virus ◽  
Virus Vaccine ◽  
Influenza Virus Vaccine ◽  
In Ovo ◽  
H9n2 Avian Influenza Virus

scholarly journals Immunity to Influenza A H9N2 Viruses Induced by Infection and Vaccination

2001 ◽  
Vol 75 (10) ◽  
pp. 4896-4901 ◽  
Author(s):  
Xiuhua Lu ◽  
Mary Renshaw ◽  
Terrence M. Tumpey ◽  
Gloria D. Kelly ◽  
Jean Hu-Primmer ◽  
...  
Keyword(s):  
Avian Influenza ◽  
Virus Vaccine ◽  
Hemagglutination Inhibition ◽  
Influenza A ◽  
Protective Efficacy ◽  
Respiratory Illness ◽  
H9n2 Virus ◽  
Pandemic Preparedness ◽  
Heterologous Challenge ◽  
Inhibition Antibody

ABSTRACT Avian influenza A H9N2 viruses are widespread among domestic poultry and were recently isolated from humans with respiratory illness in China. Two antigenically and genetically distinct groups of H9N2 viruses (G1 and G9) are prevalent in China. To evaluate a strategy for vaccination, we compared G1 and G9 viruses for their relative immunogenicity and cross-protective efficacy. Infection of BALB/c mice with representative viruses of either group protected against subsequent challenge with the homologous or heterologous H9N2 virus in the absence of detectable cross-reactive serum hemagglutination inhibition antibody. Mice injected intramuscularly with inactivated G1 whole virus vaccine were completely protected from challenge with either H9N2 virus. In contrast, mice administered inactivated G9 vaccine were only partially protected against heterologous challenge with the G1 virus. These results have implications for the development of human vaccines against H9N2 viruses, a priority for pandemic preparedness.

Sign in / Sign up

Export Citation Format

Share Document